Nov 14, 2022 08:00AM
Aug 15, 2022 07:05AM
May 16, 2022 08:30AM
May 9, 2022 08:00AM
May 9, 2022 08:00AM
Mar 4, 2022 04:06PM
Mar 4, 2022 04:05PM LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates
Feb 2, 2022 06:02AM
Feb 2, 2022 06:00AM
Dec 22, 2021 08:07AM
Dec 22, 2021 08:00AM
Nov 15, 2021 07:00AM
Oct 18, 2021 08:07AM
Oct 18, 2021 08:00AM LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children
Aug 9, 2021 08:00AM
Jun 7, 2021 06:46AM
Jun 2, 2021 07:02AM
Jun 2, 2021 07:00AM
Jan 7, 2021 08:00AM
Jan 6, 2021 08:00AM
Dec 22, 2020 08:00AM Cecilia Jones Joins LogicBio Therapeutics as Chief Financial Officer
Dec 14, 2020 08:08AM
Dec 14, 2020 08:00AM
Nov 12, 2020 04:05PM
Nov 12, 2020 04:05PM
Nov 9, 2020 06:30AM
Nov 9, 2020 06:30AM
Nov 4, 2020 07:45AM LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA)
Nov 4, 2020 07:45AM
Nov 3, 2020 04:05PM
Nov 3, 2020 04:05PM
Oct 1, 2020 09:30AM
Sep 30, 2020 06:02PM
Aug 10, 2020 06:41AM
Aug 10, 2020 06:35AM LogicBio Therapeutics Announces SUNRISE Phase 1/2 Clinical Design for LB-001 for the Treatment of Methylmalonic Acidemia in Pediatric Patients
Aug 10, 2020 06:35AM
Aug 10, 2020 06:30AM
Aug 10, 2020 06:30AM
May 11, 2020 04:05PM
May 11, 2020 04:05PM
Mar 16, 2020 04:05PM
Mar 16, 2020 04:05PM LogicBio Reports Full Year 2019 Financial Results and Provides Business Updates
Feb 11, 2020 09:22AM
Feb 10, 2020 06:01PM
Feb 10, 2020 04:28PM
Feb 10, 2020 04:05PM
Feb 10, 2020 04:05PM
Jan 10, 2020 07:06AM
Jan 10, 2020 07:05AM LogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001 for Methylmalonic Acidemia (MMA) and Highlights Key Corporate Milestones
Jan 10, 2020 07:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All